To display releases by year, please select a year below and click Filter.
August 13, 2024
GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update
View Press Release
July 31, 2024
GRAIL to Announce Second Quarter 2024 Financial Results
View Press Release
July 18, 2024
GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population
View Press Release
July 15, 2024
GRAIL Advances the Galleri® Registrational Clinical Trial Program
View Press Release
June 24, 2024
GRAIL to Begin Trading on the Nasdaq Stock Exchange
View Press Release
June 3, 2024
Illumina Board of Directors approves spin-off of GRAIL; declares spin-off dividend of GRAIL shares
View Press Release
May 13, 2024
GRAIL to Host Capital Markets Day
View Press Release
May 6, 2024
Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL
View Press Release
March 27, 2024
GRAIL Presents New Data on Galleri® and Its Methylation Platform at the Annual American Association for Cancer Research (AACR) Meeting
View Press Release
March 18, 2024
GRAIL Announces Novel Risk Classification Test to be Used in Lung Cancer Study
View Press Release
Displaying 51 - 60 of 116